| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2013 | CN103040853A Application of gardenia sesou as vision care drug ingredient |
| 04/17/2013 | CN103040852A Application of lysine as synergist for preparing antifungal drug |
| 04/17/2013 | CN103040851A Application of Houttuynoid A in preparation of blood sugar reducing medicines |
| 04/17/2013 | CN103040850A Methionine-antitumor compound medicine and preparation method thereof |
| 04/17/2013 | CN103040849A Tannic acid preparation for treating burn, bedsore and diaper dermatitis and preparation method thereof |
| 04/17/2013 | CN103040848A Medicinal composition for treating and preventing chicken proventriculitis and preparation method thereof |
| 04/17/2013 | CN103040847A Novel application of small molecule compound ZZY-0001 in preparing antitumor drugs |
| 04/17/2013 | CN103040846A Medicament for resisting platelet aggregation |
| 04/17/2013 | CN103040845A Fat emulsion injection for supplementing fat-soluble vitamins |
| 04/17/2013 | CN103040844A Two-dimensional calcium acetate composition |
| 04/17/2013 | CN103040843A Solid dispersion containing clobetasol propionate and tretinoin and preparation method thereof |
| 04/17/2013 | CN103040842A Prostaglandin pharmaceutical composition and prostaglandin medicament suppository prepared by the prostaglandin pharmaceutical composition |
| 04/17/2013 | CN103040841A Drug composition containing irbesartan and hydrochlorothiazide |
| 04/17/2013 | CN103040840A Treatment application of composition and product of composition |
| 04/17/2013 | CN103040839A Application of drug composition and product containing application |
| 04/17/2013 | CN103040838A Drug composition and application thereof |
| 04/17/2013 | CN103040837A Ophthalmologic intraocular pressure reduction drug for external use |
| 04/17/2013 | CN103040836A Use of moclobemide in prostatic cancer resistance and pharmaceutical preparation of moclobemide |
| 04/17/2013 | CN103040835A Medicinal composition containing sildenafil citrate and preparation method thereof |
| 04/17/2013 | CN103040834A Pemetrexed disodium for injection and preparation method thereof |
| 04/17/2013 | CN103040833A Pharmaceutical composition of voriconazole and preparation method |
| 04/17/2013 | CN103040832A Application of substituted cyanobenzene in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040831A Application of multi-substituted piperazinyl pyranone in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040830A Application of bi-methyl piperazinyl pyranone in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040829A Pharmaceutical composition containing lappaconitine and oxycodone |
| 04/17/2013 | CN103040828A Compound diphenoxylate tablet and preparation method thereof |
| 04/17/2013 | CN103040827A Application of antagonist SR140333 of neurokinin receptor in hepatoma treatment |
| 04/17/2013 | CN103040826A Preparation and medical application of substituted pyranone compound |
| 04/17/2013 | CN103040825A Application of piperidyl-containing pyranone compound in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040824A Signal channel inhibiting agent as well as preparation method and application thereof |
| 04/17/2013 | CN103040823A Application of vinpocetine in preparation of anti-angiogenic medicament |
| 04/17/2013 | CN103040822A Drug composition containing kurarinone compound and preparation method of drug composition |
| 04/17/2013 | CN103040821A Application of berberine in pharmacy |
| 04/17/2013 | CN103040820A Berberine taken as accelerant of histone acetylation and application thereof |
| 04/17/2013 | CN103040819A Drug composition containing mezlocillin sodium compound and preparation method of drug composition |
| 04/17/2013 | CN103040818A Drug composition containing amoxicillin sodium and clavulanate potassium compound |
| 04/17/2013 | CN103040817A Compound preparation for treating hypertension |
| 04/17/2013 | CN103040816A Drug composition for curing peptic ulcer |
| 04/17/2013 | CN103040815A Application of 2,4,6-triisopropylbenzene compounds in preparation of medicines for treating diabetes |
| 04/17/2013 | CN103040814A Application of des-O-methyllasiodiplodin in preparation of medicament for treating kidney diseases |
| 04/17/2013 | CN103040813A Application of p-chloroaniline substituted pyranone in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040812A Application of substituted pyranone compound in preparation of fungal growth inhibiting drugs |
| 04/17/2013 | CN103040811A Application of p-methoxyphenylamino pyranone in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040810A Preparation and medical application of substituted tetrahydro-pyran-4-yl ester compound |
| 04/17/2013 | CN103040809A Preparation and medical application of substituted tetrahydro-pyranyl ester compound |
| 04/17/2013 | CN103040808A Application of phenylpropionic-acid-substituted tetrahydro-pyranone in preparation of fungal infection resisting drugs |
| 04/17/2013 | CN103040807A Application of des-O-methyllasiodiplodin in preparation of medicament for treating hypertension |
| 04/17/2013 | CN103040806A Process for directionally differentiating neural stem cell into oligodendrocyte by vitue of bilobalide B |
| 04/17/2013 | CN103040805A Medical application of fargesin |
| 04/17/2013 | CN103040804A Norwogonin and application thereof to preparation of medicines for treating acinetobacter baumannii infection |
| 04/17/2013 | CN103040803A Application of 5-hydroxymethyl-2-furfural and derivatives thereof in preparation of pharmaceutical compositions for preventing and treating bone metabolic disorder diseases |
| 04/17/2013 | CN103040802A Method for inhibiting reproduction of HIV-1 (human immunodeficiency virus-1) drug-resistant virus |
| 04/17/2013 | CN103040801A Preparation and medical application of aromatic ring substituted ethyl valerate |
| 04/17/2013 | CN103040800A Application of gemfibrozil in preparation of anti-angiogenic medicaments |
| 04/17/2013 | CN103040799A Application of non-steroidal anti-inflammatory medicines in preparation of medicine for preventing and treating diabetic encephalopathy |
| 04/17/2013 | CN103040798A Bezafibrate slow release pharmaceutical composition |
| 04/17/2013 | CN103040797A Application of astaxanthin in preparing medicine for preventing embryotoxicity caused by organophosphorus pesticide |
| 04/17/2013 | CN103040796A Application of lignan reduction compounds in preparation of medicine for resisting depression |
| 04/17/2013 | CN103040795A Rotundine transdermal patch and preparation method thereof |
| 04/17/2013 | CN103040794A Nitroglycerin oral instant film and preparation method thereof |
| 04/17/2013 | CN103040793A Cefaclor oral instant film preparation and preparation method thereof |
| 04/17/2013 | CN103040791A Asiatic acid lipid nanoparticle capable of stimulating oral absorption and preparation method thereof |
| 04/17/2013 | CN103040790A Preparation method of wild cactus polysaccharide poly(lactic-co-glycolic acid) (PLGA) microcapsules |
| 04/17/2013 | CN103040789A Micro-capsule combination and preparation method thereof |
| 04/17/2013 | CN103040788A Cefuroxime axetil capsule and preparation method thereof |
| 04/17/2013 | CN103040787A Azithromycin capsule and preparation method thereof |
| 04/17/2013 | CN103040785A Permeable gastric retention tablets and preparation method thereof |
| 04/17/2013 | CN103040784A Montelukast tablet composition and preparation method thereof |
| 04/17/2013 | CN103040782A Cefixime tablets and preparation method thereof |
| 04/17/2013 | CN103040781A Pramipexole dihydrochloride tablet composition and preparation method thereof |
| 04/17/2013 | CN103040780A Rapidly disintegrating pramipexole tablet drug composition and preparation method thereof |
| 04/17/2013 | CN103040779A Oral solid medicine composition for nervous system diseases |
| 04/17/2013 | CN103040778A Azithromycin dispersible tablet, as well as preparation method and application thereof |
| 04/17/2013 | CN103040777A Olmesartan ester liposome solid preparation |
| 04/17/2013 | CN103040776A Preparation method of azithromycin dispersible tablet granule coating |
| 04/17/2013 | CN103040775A Lenampicillin hydrochloride medicinal composition and preparation method thereof |
| 04/17/2013 | CN103040774A Granulating and coating process of esomeprazole magnesium contained in esomeprazole magnesium enteric-coated tablet |
| 04/17/2013 | CN103040773A Doxycycline metal complex in a solid dosage form |
| 04/17/2013 | CN103040772A Repaglinide dispersible tablet and preparation method thereof |
| 04/17/2013 | CN103040771A Caffeine orally disintegrating tablet |
| 04/17/2013 | CN103040768A Powder mixing technology for compound antibiotic |
| 04/17/2013 | CN103040767A Stable kalii dehydrographolidi succinas freeze-dried powder injection for injection |
| 04/17/2013 | CN103040766A Drug composition containing pamidronate disodium compound |
| 04/17/2013 | CN103040765A Pharmaceutical composition containing adenosine disodium triphosphate and preparation method of pharmaceutical composition |
| 04/17/2013 | CN103040763A Labetalol hydrochloride lipidosome injection |
| 04/17/2013 | CN103040762A Pharmaceutical composition containing granisetron hydrochloride compound |
| 04/17/2013 | CN103040761A Novel metformin hydrochloride sustained release pellets and preparation method thereof |
| 04/17/2013 | CN103040758A Drug composition containing cefathiamidine compound and preparation method of drug composition |
| 04/17/2013 | CN103040756A Preparation method of mPEG epirubicin hydrochloride magnetic liposome |
| 04/17/2013 | CN103040755A APARPAR polypeptide-modified invisible liposome and drug delivery system |
| 04/17/2013 | CN103040754A Resveratrol nano-liposome and preparation method thereof |
| 04/17/2013 | CN103040753A Ginkgolide lipidosome injection |
| 04/17/2013 | CN103040751A Asarone lipidosome injection |
| 04/17/2013 | CN103040750A Agomelatine liposome solid preparation |
| 04/17/2013 | CN103040749A Sarpogrelate hydrochloride lipidosome solid preparation |
| 04/17/2013 | CN103040748A Pemetrexed disodium liposome injection |
| 04/17/2013 | CN103040747A Sodium fusidate lipidosome injection |
| 04/17/2013 | CN103040746A Palonosetron hydrochloride lipidosome injection |
| 04/17/2013 | CN103040745A Meglumine adenosine cyclophosphate lipidosome injection |
| 04/17/2013 | CN103040744A Propyl gallate liposome injection |